Please wait
0001157601EX-FILING FEESfalse 0001157601 2024-10-29 2024-10-29 0001157601 1 2024-10-29 2024-10-29 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
Form
S-8
(Form Type)
Madrigal Pharmaceuticals, Inc.
(Exact name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
 
               
Security Type  
Security
Class
Title
   Fee
Calculation
Rule		   Amount
Registered
(1)
  
Proposed
Maximum
Offering
Price Per
Unit
  
Maximum
Aggregate
Offering
Price
  
Fee
Rate
  
Amount of
Registration
Fee
               
Equity   Common Stock, $0.0001 par value per share   457(h)   750,000
(2)
   $203.41
(3)
   $152,557,500.00   0.00015310   $23,356.56
         
Total Offering Amounts     $152,557,500.00     $23,356.56
         
Total Fee Offsets         — 
         
Net Fee Due               $23,356.56
 
(1)
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form
S-8
(“Registration Statement”) shall also cover any additional shares of common stock, $0.0001 par value per share (the “Common Stock”) of Madrigal Pharmaceuticals, Inc. (the “Registrant”) that become issuable under the Madrigal Pharmaceuticals, Inc. Amended 2015 Stock Plan, as amended and restated on June 25, 2024 (the “Plan”), by reason of any stock dividend, stock split, recapitalization or any other similar transactions.
 
(2)
Represents an increase of 750,000 shares of Common Stock available for issuance under the Plan, as approved on June 25, 2024.
 
(3)
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457 of the Securities Act, and based on $203.41, the average of the high and low sale prices of the Common Stock as reported on Nasdaq on October 24, 2024 (such date being within five business days of the date that this Registration Statement was filed with the Commission).